Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Aphasic AD (Logopenic Variant PPA)

NCT03887481 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03887481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03887481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Aphasic AD (Logopenic Variant PPA)
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Recruiting
Start date
October 15, 2022
Completion date
October 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

logopenic progressive aphasia, primary progressive aphasia